fda retatrutide Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Buy Retatrutide — Best Research

The underpinning biological mechanisms are also considered

Researchers have developed specific dietary guidelines to avoid GLP-1 nausea, including: Avoid trigger foods

Common Side Effects Nausea (most common, peaks during dose escalation) Diarrhea, constipation, vomiting Decreased appetite, fatigue, headache Injection-site reactions (injectable forms) Rare: pancreatitis, gallbladder disease, kidney injury FDA boxed warning for medullary thyroid carcinoma (do not use with personal or family history of MTC or MEN2) How to Start GLP-1 Treatment See a clinician in-person primary care, endocrinology, obesity medicine, or US telehealth

Its dual action, promoting tissue recovery and reducing inflammation, makes it a powerful candidate for people dealing with IBS, leaky gut, ulcers, or other digestive integrity issues

Does everyone need to drink electrolytes